Oral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial. [electronic resource]
Producer: 20140204Description: 85-93 p. digitalISSN:- 1875-8894
- Absorptiometry, Photon
- Adolescent
- Adult
- Alkaline Phosphatase -- blood
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Cerebral Palsy -- pathology
- Child
- Collagen Type I -- blood
- Double-Blind Method
- Etidronic Acid -- administration & dosage
- Female
- Humans
- Lumbar Vertebrae -- diagnostic imaging
- Male
- Osteocalcin -- blood
- Peptides -- blood
- Risedronic Acid
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.